Ghent University Academic Bibliography

Your filters: cql: author="Canonica, Giorgio Walter" or (type any "bookEditor issueEditor" and editor="Canonica, Gio...

Add to list
- Journal Article
- A1
- open access
Real-life effectiveness of mepolizumab in severe asthma : a systematic literature review

Elliot Israel, Giorgio Walter Canonica, Guy Brusselle (UGent) , Shibing Yang, Peter H. Howarth, Amber L. Martin, Maria Koufopoulou, Steven G. Smith and Rafael Alfonso-Cristancho

(2022) JOURNAL OF ASTHMA. 59(11). p.2201-2217
Add to list
- Journal Article
- A1
- open access
Association between a type 2 inflammatory disease burden score and outcomes among patients with asthma

David Price, Andrew Menzies-Gow, Claus Bachert (UGent) , Giorgio Walter Canonica, Janwillem Kocks, Asif H Khan, Fen Ye, Paul J Rowe, Yufang Lu, Siddhesh Kamat, et al.

(2021) JOURNAL OF ASTHMA AND ALLERGY. 14. p.1173-1183
Add to list
- Conference Paper
- C3
SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials

Joaquim Mullol, Giorgio Walter Canonica, Martin Wagenmann, Andre Coste, Peter Hellings, Scott Nash, Siddhesh Kamat, Urvi Mujumdar, Jérôme Msihid, Asif H. Khan, et al.

(2021) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 58(supplement 65).
Add to list
- Miscellaneous
3TR : a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD

Celeste Porsbjerg, Anke H. Maitland-van der Zee, Guy Brusselle (UGent) , Giorgio Walter Canonica, Alvar Agusti, Rosa Faner, Claus F. Vogelmeier, Martijn Nawijn, Maarten van den Berge, Franca Rusconi, et al.

(2021) EUROPEAN RESPIRATORY JOURNAL. 58(4).
Add to list
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps : a systematic review for the EAACI guidelines

Ioana Agache, Yang Song, Pablo Alonso-Coello, Yasmin Vogel, Claudio Rocha, Ivan Sola, Marilina Santero, Cezmi Akdis, Mubeccel Akdis, Giorgio Walter Canonica, et al.

(2021) ALLERGY. 76(8). p.2337-2353
Add to list
- Journal Article
- A1
- open access
Eosinophilic and noneosinophilic asthma : an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort

Liam G. Heaney, Luis Perez de Llano, Mona Al-Ahmad, Vibeke Backer, John Busby, Giorgio Walter Canonica, George C. Christoff, Borja G. Cosio, J. Mark FitzGerald, Enrico Heffler, et al.

(2021) CHEST. 160(3). p.814-830
Add to list
COVID‐19 pandemic : practical considerations on the organization of an allergy clinic : an EAACI/ARIA position paper

Oliver Pfaar, Ludger Klimek, Marek Jutel, Cezmi A. Akdis, Jean Bousquet, Heimo Breiteneder, Sharon Chinthrajah, Zuzana Diamant, Thomas Eiwegger, Wytske J. Fokkens, et al.

(2021) ALLERGY. 76(3). p.648-676
Add to list
- Journal Article
- A1
- open access
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

Jean Bousquet, Marek Jutel, Cezmi A. Akdis, Ludger Klimek, Oliver Pfaar, Kari C. Nadeau, Thomas Eiwegger, Anna Bedbrook, Ignacio J. Ansotegui, Josep M. Anto, et al.

(2021) ALLERGY. 76(3). p.689-697
Add to list
- Conference Paper
- C3
Dupilumab reduces severe outpatient asthma exacerbations, cumulative dose, and total number of days of systemic corticosteroid use among patients with moderate-to-severe type-2 asthma

Giorgio Walter Canonica, Robert Zeiger, Mario Castro, Jerome Msihid, Benjamin Ortiz, Nami Pandit-Abid, Siddhesh Kamat and Asif H. Khan

(2020) CHEST. In Chest 158(4). p.A1810-A1812
Add to list
- Journal Article
- A1
- open access
Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care

Hilda J. I. De Jong, Jaco Voorham, Glenis K. Scadding, Claus Bachert (UGent) , Giorgio Walter Canonica, Peter Smith, Ulrich Wahn, Dermot Ryan, Jose A. Castillo, Victoria A. Carter, et al.

(2020) WORLD ALLERGY ORGANIZATION JOURNAL. 13(12).

Academic Bibliography

Real-life effectiveness of mepolizumab in severe asthma : a systematic literature review

Association between a type 2 inflammatory disease burden score and outcomes among patients with asthma

SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials

3TR : a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD

Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps : a systematic review for the EAACI guidelines

Eosinophilic and noneosinophilic asthma : an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort

COVID‐19 pandemic : practical considerations on the organization of an allergy clinic : an EAACI/ARIA position paper

ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

Dupilumab reduces severe outpatient asthma exacerbations, cumulative dose, and total number of days of systemic corticosteroid use among patients with moderate-to-severe type-2 asthma

Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care

Contents

Support

Contact